Literature DB >> 28825711

Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529.

Marie Pancera1, Yen-Ting Lai1, Tatsiana Bylund1, Aliaksandr Druz1, Sandeep Narpala1, Sijy O'Dell1, Arne Schön2, Robert T Bailer1, Gwo-Yu Chuang1, Hui Geng1, Mark K Louder1, Reda Rawi1, Djade I Soumana1, Andrés Finzi3, Alon Herschhorn4, Navid Madani4, Joseph Sodroski4, Ernesto Freire2, David R Langley5, John R Mascola1, Adrian B McDermott1, Peter D Kwong1.   

Abstract

The HIV-1 envelope (Env) spike is a conformational machine that transitions between prefusion (closed, CD4- and CCR5-bound) and postfusion states to facilitate HIV-1 entry into cells. Although the prefusion closed conformation is a potential target for inhibition, development of small-molecule leads has been stymied by difficulties in obtaining structural information. Here, we report crystal structures at 3.8-Å resolution of an HIV-1-Env trimer with BMS-378806 and a derivative BMS-626529 for which a prodrug version is currently in Phase III clinical trials. Both lead candidates recognized an induced binding pocket that was mostly excluded from solvent and comprised of Env elements from a conserved helix and the β20-21 hairpin. In both structures, the β20-21 region assumed a conformation distinct from prefusion-closed and CD4-bound states. Together with biophysical and antigenicity characterizations, the structures illuminate the allosteric and competitive mechanisms by which these small-molecule leads inhibit CD4-induced structural changes in Env.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28825711      PMCID: PMC5676566          DOI: 10.1038/nchembio.2460

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  58 in total

1.  Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

Authors:  Qian Zhao; Liying Ma; Shibo Jiang; Hong Lu; Shuwen Liu; Yuxian He; Nathan Strick; Nouri Neamati; Asim Kumar Debnath
Journal:  Virology       Date:  2005-09-01       Impact factor: 3.616

2.  HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.

Authors:  Susan M Schader; Susan P Colby-Germinario; Peter K Quashie; Maureen Oliveira; Ruxandra-Ilinca Ibanescu; Daniela Moisi; Thibault Mespléde; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

3.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

4.  Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects.

Authors:  Richard E Nettles; Dirk Schürmann; Li Zhu; Michele Stonier; Shu-Pang Huang; Ih Chang; Caly Chien; Mark Krystal; Megan Wind-Rotolo; Neelanjana Ray; George J Hanna; Richard Bertz; Dennis Grasela
Journal:  J Infect Dis       Date:  2012-08-14       Impact factor: 5.226

5.  Spontaneous rearrangement of the β20/β21 strands in simulations of unliganded HIV-1 glycoprotein, gp120.

Authors:  Indira H Shrivastava; Kaylee Wendel; Judith M LaLonde
Journal:  Biochemistry       Date:  2012-09-21       Impact factor: 3.162

6.  Compartmental absorption modeling and site of absorption studies to determine feasibility of an extended-release formulation of an HIV-1 attachment inhibitor phosphate ester prodrug.

Authors:  Jonathan Brown; Caly Chien; Peter Timmins; Andrew Dennis; Walter Doll; Erik Sandefer; Richard Page; Richard E Nettles; Li Zhu; Dennis Grasela
Journal:  J Pharm Sci       Date:  2013-04-05       Impact factor: 3.534

7.  Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions.

Authors:  Tao Wang; Zhongxing Zhang; Owen B Wallace; Milind Deshpande; Haiquan Fang; Zheng Yang; Lisa M Zadjura; Donald L Tweedie; Stella Huang; Fang Zhao; Sunanda Ranadive; Brett S Robinson; Yi-Fei Gong; Keith Ricarrdi; Timothy P Spicer; Carol Deminie; Ronald Rose; Hwei-Gene Heidi Wang; Wade S Blair; Pei-Yong Shi; Pin-Fang Lin; Richard J Colonno; Nicholas A Meanwell
Journal:  J Med Chem       Date:  2003-09-25       Impact factor: 7.446

8.  Broad neutralization coverage of HIV by multiple highly potent antibodies.

Authors:  Laura M Walker; Michael Huber; Katie J Doores; Emilia Falkowska; Robert Pejchal; Jean-Philippe Julien; Sheng-Kai Wang; Alejandra Ramos; Po-Ying Chan-Hui; Matthew Moyle; Jennifer L Mitcham; Phillip W Hammond; Ole A Olsen; Pham Phung; Steven Fling; Chi-Huey Wong; Sanjay Phogat; Terri Wrin; Melissa D Simek; Wayne C Koff; Ian A Wilson; Dennis R Burton; Pascal Poignard
Journal:  Nature       Date:  2011-09-22       Impact factor: 49.962

9.  CD4-induced activation in a soluble HIV-1 Env trimer.

Authors:  Miklos Guttman; Natalie K Garcia; Albert Cupo; Tsutomu Matsui; Jean-Philippe Julien; Rogier W Sanders; Ian A Wilson; John P Moore; Kelly K Lee
Journal:  Structure       Date:  2014-06-12       Impact factor: 5.006

10.  A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Authors:  Rogier W Sanders; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Anila Yasmeen; Natalia de Val; Helen J Kim; Claudia Blattner; Alba Torrents de la Peña; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Marit J van Gils; C Richter King; Ian A Wilson; Andrew B Ward; P J Klasse; John P Moore
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

View more
  46 in total

1.  Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.

Authors:  Yijun Zhang; James H Chapman; Asim Ulcay; Richard E Sutton
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands.

Authors:  Maolin Lu; Xiaochu Ma; Nick Reichard; Daniel S Terry; James Arthos; Amos B Smith; Joseph G Sodroski; Scott C Blanchard; Walther Mothes
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

3.  Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins.

Authors:  Shitao Zou; Shijian Zhang; Althea Gaffney; Haitao Ding; Maolin Lu; Jonathan R Grover; Mark Farrell; Hanh T Nguyen; Connie Zhao; Saumya Anang; Meiqing Zhao; Mohammadjavad Mohammadi; Scott C Blanchard; Cameron Abrams; Navid Madani; Walther Mothes; John C Kappes; Amos B Smith; Joseph Sodroski
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

4.  Effects of the SOS (A501C/T605C) and DS (I201C/A433C) Disulfide Bonds on HIV-1 Membrane Envelope Glycoprotein Conformation and Function.

Authors:  Hanh T Nguyen; Nirmin Alsahafi; Andrés Finzi; Joseph G Sodroski
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

5.  Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation.

Authors:  Francesca Curreli; Shahad Ahmed; Sofia M Benedict Victor; Ildar R Iusupov; Dmitry S Belov; Pavel O Markov; Alexander V Kurkin; Andrea Altieri; Asim K Debnath
Journal:  J Med Chem       Date:  2020-02-17       Impact factor: 7.446

6.  Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer.

Authors:  Peng Zhang; Jason Gorman; Hui Geng; Qingbo Liu; Yin Lin; Yaroslav Tsybovsky; Eden P Go; Barna Dey; Tsion Andine; Alice Kwon; Mit Patel; Deepali Gururani; Ferzan Uddin; Christina Guzzo; Raffaello Cimbro; Huiyi Miao; Krisha McKee; Gwo-Yu Chuang; Loïc Martin; Francesca Sironi; Mauro S Malnati; Heather Desaire; Edward A Berger; John R Mascola; Michael A Dolan; Peter D Kwong; Paolo Lusso
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

7.  Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.

Authors:  Zhao Dang; Hua Xie; Lei Zhu; Qingye Zhang; Zhijun Li; Li Huang; Chin-Ho Chen
Journal:  ACS Med Chem Lett       Date:  2017-10-09       Impact factor: 4.345

8.  Antigenicity and Immunogenicity of HIV-1 Envelope Trimers Complexed to a Small-Molecule Viral Entry Inhibitor.

Authors:  S Munir Alam; Kenneth Cronin; Robert Parks; Kara Anasti; Haitao Ding; Eden P Go; Heather Desaire; Amanda Eaton; David Montefiori; Joseph Sodroski; John Kappes; Barton F Haynes; Kevin O Saunders
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

9.  Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120.

Authors:  Francesca Curreli; Dmitry S Belov; Young Do Kwon; Ranjith Ramesh; Anna M Furimsky; Kathleen O'Loughlin; Patricia C Byrge; Lalitha V Iyer; Jon C Mirsalis; Alexander V Kurkin; Andrea Altieri; Asim K Debnath
Journal:  Eur J Med Chem       Date:  2018-05-12       Impact factor: 6.514

Review 10.  The Conformational States of the HIV-1 Envelope Glycoproteins.

Authors:  Qian Wang; Andrés Finzi; Joseph Sodroski
Journal:  Trends Microbiol       Date:  2020-05-14       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.